Form 4 Filing: Xavier Ramnik Acquires (Grant) shares of $MLTX

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

MoonLake Immunotherapeutics

Ticker: $MLTX

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-06-17

Shares: 22,195

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Xavier Ramnik, holds the title of Director at MoonLake Immunotherapeutics.

On 2026-06-17, the insider transacted 22,195 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Xavier Ramnik (Director) was granted $0 of $MLTX

Post-Transaction Position: 22,195 shares

SEC Accession No: 0001213900-26-070255 (CIK: 1920780)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$MLTX Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$MLTX News Coverage